GlobalData Plc

The Asia-Pacific (APAC) digit replacement market, which covers Australia, China, India, Japan, New Zealand, South Korea, and Taiwan, is set to rise from $0.8 million in 2016 to around $1.2 million by 2023, representing a compound annual growth rate (CAGR) of 6.3%, according to GlobalData, a recognized leader in providing business information and analytics.

The company’s latest report states that Australia represented the largest portion of the market in 2015, holding nearly 25% of the regional revenue, though it is expected to be surpassed by China during the forecast period. South Korea is expected to be the fastest-growing country in the APAC and global market through 2023, with a CAGR of 10.4%.

Key drivers of this relatively strong growth include the aging population and rising prevalence of arthritis, materials research into more durable and biocompatible implants, and long term results that showcase the benefits of digit arthroplasty compared to alternative treatments.

Tobe Madu, MSc, Healthcare Analyst for GlobalData, explains: “Implant arthroplasty of the finger joints is a viable treatment option for arthritis in the proximal interphalangeal and metacarpophalangeal joints. However, the efficacy of these devices is questionable given their propensity to fracture, react with bone, or dislocate due to the large range of motion that the finger experiences.

“This has led to slow adoption among surgeons and patients who prefer the pain relief and durability of fusion over maintaining function in these joints. Continued research on the stability, biocompatibility, and anatomic soundness of these devices is necessary to grow the market, as positive long-term data will increase physician and patient adoption.”

GlobalData believes the slowest growth in the APAC digit replacement market to 2023 will be observed in Australia due to the fact that it has one of the more developed healthcare systems in the region with a relatively mature orthopedic market.

– Information based on GlobalData’s report: MediPoint: Digit Replacement – APAC Analysis and Market Forecasts.

Related Reports

From GlobalData’s report:

MediPoint: Digit Replacement – APAC Analysis and Market Forecasts Free Sample

Related GlobalData Reports

Related Intelligence

Want more Insight like this?

Our interactive subscription platform has the most comprehensive data and analysis in your industry.

Request a Demo

Related Consulting

How can we help your business?

Our consultants are skilled in every specialist market niche to deliver solutions specifically designed for your individual requirements.

Request a Callback

    Press Release Healthcare

    Late-stage CKD-induced comorbidity therapeutics market to reach $10.5bn by 2026

    Sales for chronic kidney disease (CKD)-induced hyperparathyroidism (HPT), hyperphosphatemia (HP), and hyperkalemia (HK) therapeutics were estimated to be $4.2bn across the seven major markets (7MM*) in 2016. This is expected to grow to $10.5bn in 2026, at a Compound Annual Growth Rate (CAGR) of 9.5%, according to GlobalData, a leading data and analytics company.

    Press Release Healthcare

    Majority of oncology clinical trials in China failed to meet enrolment targets

    The majority of oncology clinical trials in China that had a start date between 1 January 2012 and 31 December 2017 failed to meet the planned enrolment targets, according to GlobalData, a leading data and analytics company. The company identified and analyzed enrollment efficiencies of 324 clinical trials during the period and found that on...

    Press Release Healthcare

    Need for supportive care in oncology will increase during the next decade

    The need for effective supportive care in oncology will increase in the next decade as patients continue to live longer and cancer progresses to become more like a chronic disease. This includes the need for chemotherapy-related conditions, as chemotherapy will remain the backbone of cancer therapy for the foreseeable future, observes GlobalData, a leading data and analytics company.

    Press Release Healthcare

    World Cancer Day: What will 2018 mean for cancer research and treatment?

    The theme of this year’s World Cancer Day held on 4th February of “We can. I can.” aimed to reinforce the public message that all individuals and groups can play their part in reducing the global burden of cancer. Indeed in recent years many events have involved collaborations between traditional drug developers, cancer treatment professionals and those of varying disciplines. Examples include the IBM Watson supercomputer which is helping physicians make treatment decisions and the development of other databases such as ASCO’s CancerLinQ which assists oncologists in monitoring and analyzing patient data.

    Press Release Healthcare

    Melanoma sales are projected to rise to $5.5bn in 2026

    The value of the melanoma market was estimated to be $3.3bn across the seven major markets (7MM*) in 2016. This is expected to grow to $5.5bn in 2026, at a Compound Annual Growth Rate (CAGR) of 5.3%, according to GlobalData, a leading data and analytics company.

Media Enquiries

If you are a member of the press or media and require any further information, please get in touch, as we’re very happy to help.

Emailpr@globaldata.com
PhoneEMEA: +44 207 832 4399
PhoneAPAC: +91 40 6616 6809
Onlinecontact online

56% of #consumers are concerned about the impact of diet. Join us for more insight @incosmetics #cosmetics #trends… https://t.co/wJOJOqYIJF